Direct oral anticoagulants for unusual‐site venous thromboembolism
Abstract Direct oral anticoagulants (DOACs) are currently the preferred oral anticoagulant treatment for most of the patients with deep vein thrombosis of the lower extremities and/or pulmonary embolism. DOACs have several advantages over vitamin K antagonists, such as availability of fixed dosages,...
Main Authors: | Nicoletta Riva, Walter Ageno |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12480 |
Similar Items
-
Splanchnic Vein Thrombosis: Current Perspectives
by: Valeriani E, et al.
Published: (2019-10-01) -
Venous thrombosis in subclavian, axillary, brachial veins with extension to internal jugular vein, right sigmoid sinus and simultaneous pulmonary embolism
by: Babak Tamizifar, et al.
Published: (2013-01-01) -
Significance of factor II G20210A mutation in Budd-Chiari syndrome and portal vein thrombosis
by: ZHANG Wenwen
Published: (2015-02-01) -
Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis
by: Sobieraj, Diana M., et al.
Published: (2015) -
Thrombosis of the Abdominal Veins in Childhood
by: Riten Kumar, et al.
Published: (2017-09-01)